Latest News

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

March 25th 2025

Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.

Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics
Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics

March 21st 2025

Universal ED Syphilis Screening Outperforms Targeted Approaches, Study Shows
Universal ED Syphilis Screening Outperforms Targeted Approaches, Study Shows

March 20th 2025

Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV / Image credit: ©Sherry Young/AdobeStock
Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV

March 19th 2025

The Superbug Challenge: Medicine's Essential Fight Against Antimicrobial Resistance / image credit Priya Nori, MD, Montefiore Health System
The Superbug Challenge: Medicine's Essential Fight Against Antimicrobial Resistance

February 28th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.